Chronic lymphocytic leukaemia and acute myeloid leukaemia are not associated with AKT1 pleckstrin homology domain (E17K) mutations

British Journal of Haematology

Volumn 141, Issue 5, 2008, Pages 742-743

  Zenz, T ^a   Dohner K ^a   Denzel, T ^a   Dohner H ^a   Stilgenbauer, S ^a   Bullinger, L ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Acute myeloid leukaemia; AKT1; Chronic lymphocytic leukaemia; Mutation; PI3K AKT signaling

Indexed keywords

PLECKSTRIN;

ACUTE GRANULOCYTIC LEUKEMIA; AKT1 GENE; CANCER PATIENT; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; DNA EXTRACTION; GENE DUPLICATION; GENE INACTIVATION; GENE MUTATION; GENOTYPE; HUMAN; LETTER; MALIGNANT TRANSFORMATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; TUMOR GENE;

BLOOD PROTEINS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKEMIA, MYELOID, ACUTE; MUTATION; NEOPLASM PROTEINS; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 43449092194     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07113.x     Document Type: Letter

References (8)

1. Carpten, J.D., Faber, A.L., Horn, C., Donoho, G.P., Briggs, S.L., Robbins, C.M., Hostetter, G., Boguslawski, S., Moses, T.Y., Savage, S., Uhlik, M., Lin, A., Du, J., Qian, Y.W., Zeckner, D.J., Tucker-Kellogg, G., Touchman, J., Patel, K., Mousses, S., Bittner, M., Schevitz, R., Lai, M.H., Blanchard, K.L. Thomas, J.E. (2007) A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature, 448, 439 444.
2. Kienle, D., Katzenberger, T., Ott, G., Saupe, D., Benner, A., Kohlhammer, H., Barth, T.F., Höller, S., Kalla, J., Rosenwald, A., Müller-Hermelink, H.K., Möller, P., Lichter, P., Döhner, H. Stilgenbauer, S. (2007) Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factors. Journal of Clinical Oncology, 25, 2770 2777.
3. Leupin, N., Cenni, B., Novak, U., Hügli, B., Graber, H.U., Tobler, A. Fey, M.F. (2003) Disparate expression of the PTEN gene: a novel finding in B-cell chronic lymphocytic leukaemia (B-CLL). British Journal of Haematology, 121, 97 100.
4. Liu, T.C., Lin, P.M., Chang, J.G., Lee, J.P., Chen, T.P. Lin, S.F. (2000) Mutation analysis of PTEN/MMAC1 in acute myeloid leukemia. American Journal of Hematology, 63, 170 175.
5. Longo, P.G., Laurenti, L., Gobessi, S., Petlickovski, A., Pelosi, M., Chiusolo, P., Sica, S., Leone, G. Efremov, D.G. (2007) The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease. Leukemia, 21, 110 120.
6. Manning, B.D. Cantley, L.C. (2007) AKT/PKB signaling: navigating downstream. Cell, 129, 1261 1274.
7. Tibes, R., Kornblau, S.M., Qiu, Y., Mousses, S.M., Robbins, C., Moses, T. Carpten, J.D. (2008) PI3K/AKT pathway activation in acute myeloid leukaemias is not associated with AKT1 pleckstrin homology domain mutation. British Journal of Haematology, 140, 344 347.
8. Vivanco, I. Sawyers, C.L. (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nature Reviews Cancer, 2, 489 501.